NEW YORK (GenomeWeb) ­– California-based precision cancer blood-testing company CellMax Life has partnered with Core Diagnostics, a clinical laboratory in India, to introduce two precision cancer risk assessment and screening tests in that country.

Core Diagnostics focuses on next generation diagnostics for disease stratification and therapy selection, with initial test offerings in the areas of cardiology, oncology, reproductive disorders, endocrinology, and infectious diseases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.